- Report
- October 2025
- 160 Pages
Global
From €2989EUR$3,358USD£2,612GBP
€3517EUR$3,950USD£3,073GBP
- Report
- August 2025
- 150 Pages
Global
From €2989EUR$3,358USD£2,612GBP
€3517EUR$3,950USD£3,073GBP
- Report
- August 2025
- 150 Pages
Global
From €2989EUR$3,358USD£2,612GBP
€3517EUR$3,950USD£3,073GBP
- Report
- August 2025
- 150 Pages
Global
From €2989EUR$3,358USD£2,612GBP
€3517EUR$3,950USD£3,073GBP
- Report
- June 2025
Global
From €6677EUR$7,500USD£5,835GBP
- Report
- June 2025
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP
- Report
- January 2025
- 150 Pages
United States
From €5297EUR$5,950USD£4,629GBP
- Report
- December 2025
Europe
From €1865EUR$2,095USD£1,630GBP
€3552EUR$3,990USD£3,104GBP
- Report
- September 2025
- 28 Pages
United States
From €995EUR$1,197USD£900GBP
- Report
- September 2025
- 28 Pages
United States
From €995EUR$1,197USD£900GBP
- Report
- May 2021
- 177 Pages
United States
€1331EUR$1,495USD£1,163GBP
- Report
- September 2023
- 135 Pages
Global
From €4006EUR$4,500USD£3,501GBP
- Report
- May 2023
- 169 Pages
Global
From €2092EUR$2,350USD£1,828GBP
- Report
- February 2024
- 140 Pages
Global
From €1996EUR$2,243USD£1,745GBP
€2662EUR$2,990USD£2,326GBP
- Report
- February 2021
Global
From €2504EUR$2,813USD£2,188GBP
€3338EUR$3,750USD£2,917GBP
- Report
- July 2020
- 38 Pages
Global
From €1758EUR$1,975USD£1,536GBP
- Report
- February 2023
- 152 Pages
Global
From €2226EUR$2,500USD£1,945GBP
- Report
- March 2024
- 195 Pages
China
From €3561EUR$4,000USD£3,112GBP
- Report
- March 2024
- 57 Pages
China
From €1602EUR$1,800USD£1,400GBP
- Report
- July 2024
- 140 Pages
United States
From €5297EUR$5,950USD£4,629GBP

The AIDS market within the context of Allergy and Immunology is focused on the development of treatments and therapies for HIV/AIDS. This includes the development of drugs to treat HIV infection, as well as vaccines and other therapies to prevent the spread of the virus. Additionally, research is being conducted to better understand the mechanisms of HIV infection and the development of new treatments.
The market is highly competitive, with many companies vying for a share of the market. Companies such as Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and ViiV Healthcare are all major players in the AIDS market. Other companies such as AbbVie, Janssen, and Pfizer are also involved in the development of treatments and therapies for HIV/AIDS. Show Less Read more